Haematologica, Vol 92, Issue 9, 1279-1281 doi:10.3324/haematol.10975
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grandjenette, C.
Right arrow Articles by Feugier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grandjenette, C.
Right arrow Articles by Feugier, P.

Chronic Lymphocytic Leukemia

Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells

Cindy Grandjenette*,+, Anne Kennel*,+, Gilbert C. Faure*, Marie C. Béné*, Pierre Feugier°,

* Laboratoire d’Immunologie, EA3441-IFR 111, Faculté de Médecine Nancy Université and CHU de Nancy, 9 Avenue de la Forêt de Haye, BP 184, 54500 Vandoeuvre les Nancy, France
° Service d’Hématologie Adulte, CHU de Nancy, Allée du Morvan, 54500 Vandoeuvre les Nancy, France

Correspondence: Pierre Feugier, Hématologie Adulte, Hôpitaux de Brabois, Allée du Morvan, 54 500 Vandoeuvre les Nancy, France. Phone: international +33.383153282. Fax: international +33.383153558. E-mail: p.feugier{at}chunancy.fr

This study reports that B-chronic lymphocytic leukemia (B-CLL) cells display the same pattern of toll-like receptors (TLRs) proteins expression as normal B-cells, yet with overexpression of TLR9. Furthermore, TLR7 and TLR9 appear to be functional and liable to respond to specific ligands, respectively imidazoquinolines and CpG-ODN thus potentially opening new therapeutic approaches.

Key words: TLR, B-CLL, imiquimod, ODN.